Higher-dose version of Wegovy with three times the semaglutide receives FDA approval

This post was originally published on this site.

A higher-strength formulation known as Wegovy HD, containing 7.2 mg of the active compound, has been developed to assist adult patients in achieving and sustaining significant reductions in body weight over an extended period.

Leave a Comment

Your email address will not be published. Required fields are marked *